FR2679236B1 - Nouveaux sterouides substitues en position 6, leurs procedes d'obtention et des compositions pharmaceutiques en renfermant. - Google Patents

Nouveaux sterouides substitues en position 6, leurs procedes d'obtention et des compositions pharmaceutiques en renfermant.

Info

Publication number
FR2679236B1
FR2679236B1 FR9109097A FR9109097A FR2679236B1 FR 2679236 B1 FR2679236 B1 FR 2679236B1 FR 9109097 A FR9109097 A FR 9109097A FR 9109097 A FR9109097 A FR 9109097A FR 2679236 B1 FR2679236 B1 FR 2679236B1
Authority
FR
France
Prior art keywords
same
sterouides
substituted
novel
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9109097A
Other languages
English (en)
Other versions
FR2679236A1 (fr
Inventor
Robert Bucourt
Alain Piasco
Claude Tchernatinsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Theramex SAM
Original Assignee
Laboratoire Theramex SAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9109097A priority Critical patent/FR2679236B1/fr
Application filed by Laboratoire Theramex SAM filed Critical Laboratoire Theramex SAM
Priority to PL92302050A priority patent/PL172677B1/pl
Priority to HU9400134A priority patent/HU219456B/hu
Priority to AU23884/92A priority patent/AU2388492A/en
Priority to PCT/FR1992/000697 priority patent/WO1993002095A1/fr
Priority to KR1019940700153A priority patent/KR100249554B1/ko
Priority to CA002113475A priority patent/CA2113475A1/fr
Priority to PL92315036A priority patent/PL172522B1/pl
Priority to PL92315037A priority patent/PL172502B1/pl
Priority to BR9206282A priority patent/BR9206282A/pt
Priority to JP5502638A priority patent/JPH06509108A/ja
Priority to EP92916536A priority patent/EP0595990A1/fr
Priority to TNTNSN92064A priority patent/TNSN92064A1/fr
Publication of FR2679236A1 publication Critical patent/FR2679236A1/fr
Priority to OA60456A priority patent/OA09929A/fr
Priority to NO940159A priority patent/NO305961B1/no
Priority to FI940223A priority patent/FI940223A/fi
Priority to US08/643,623 priority patent/US5795884A/en
Priority to AU61966/96A priority patent/AU691431B2/en
Publication of FR2679236B1 publication Critical patent/FR2679236B1/fr
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9109097A 1991-07-18 1991-07-18 Nouveaux sterouides substitues en position 6, leurs procedes d'obtention et des compositions pharmaceutiques en renfermant. Expired - Fee Related FR2679236B1 (fr)

Priority Applications (18)

Application Number Priority Date Filing Date Title
FR9109097A FR2679236B1 (fr) 1991-07-18 1991-07-18 Nouveaux sterouides substitues en position 6, leurs procedes d'obtention et des compositions pharmaceutiques en renfermant.
EP92916536A EP0595990A1 (fr) 1991-07-18 1992-07-17 Nouveaux steroides substitues en position 6 leurs procedes d'obtention et des compositions pharmaceutiques en renfermant
HU9400134A HU219456B (hu) 1991-07-18 1992-07-17 6-Helyzetben szubsztituált szteroidok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények
PCT/FR1992/000697 WO1993002095A1 (fr) 1991-07-18 1992-07-17 Nouveaux steroides substitues en position 6 leurs procedes d'obtention et des compositions pharmaceutiques en renfermant
KR1019940700153A KR100249554B1 (ko) 1991-07-18 1992-07-17 6-치환된 스테로이드, 그것의 제조방법 및 그것을 포함하는 제약학적 조성물
CA002113475A CA2113475A1 (fr) 1991-07-18 1992-07-17 Nouveaux steroides substitues en position 6 leurs procedes d'obtention et des compositions pharmaceutiques en renfermant
PL92315036A PL172522B1 (pl) 1991-07-18 1992-07-17 Sposób wytwarzania nowych 6-alkilopodstawionych pochodnych 3-keto- ?-4,6-pregnadienu PL
PL92315037A PL172502B1 (pl) 1991-07-18 1992-07-17 Sposób wytwarzania nowych 6-hydroksymetylopodstawionych pochodnych 3-keto- ? - 4,6-pregnadienu PL
BR9206282A BR9206282A (pt) 1991-07-18 1992-07-17 Novos esteróides substituídos na posição 6,processos para sua produção e composições farmacêuticas contendo os citados esteróides
JP5502638A JPH06509108A (ja) 1991-07-18 1992-07-17 ６位に置換された新規ステロイド、それらの製造方法およびそれらを含む医薬組成物
PL92302050A PL172677B1 (en) 1991-07-18 1992-07-17 Method of obtaining novel 3,20-diketo-19-norpregna-4-enes substituted at position 6
AU23884/92A AU2388492A (en) 1991-07-18 1992-07-17 Novel 6-substituted steroids, methods for producing same and pharmaceutical compositions containing said steroids
TNTNSN92064A TNSN92064A1 (fr) 1991-07-18 1992-07-20 Nouveaux steroides substitues en position 6 leurs procedes d'obtention et des compositions pharmaceutiques en renfermant
OA60456A OA09929A (fr) 1991-07-18 1994-01-14 Nouveaux stéroides stubstitués en position 6 leurs procédés d'obtention et des compositions pharmaceutiques en renfermant
NO940159A NO305961B1 (no) 1991-07-18 1994-01-17 19-nor-pregnaner og farmasoeytiske preparater som inneholder minst ett slikt steroid
FI940223A FI940223A (fi) 1991-07-18 1994-01-17 Uusia 6-substituoituja steroideja, menetelmiä niiden valmistamiseksi ja farmaseuttisia koostumuksia, jotka sisältävät näitä steroideja
US08/643,623 US5795884A (en) 1991-07-18 1996-05-06 3-keto-nor-pregnenes substituted in the 6-position and treatment of menopause
AU61966/96A AU691431B2 (en) 1991-07-18 1996-08-08 Novel 6-substituted steroids methods for producing same and pharmaceutical compositions containing said steroids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9109097A FR2679236B1 (fr) 1991-07-18 1991-07-18 Nouveaux sterouides substitues en position 6, leurs procedes d'obtention et des compositions pharmaceutiques en renfermant.

Publications (2)

Publication Number Publication Date
FR2679236A1 FR2679236A1 (fr) 1993-01-22
FR2679236B1 true FR2679236B1 (fr) 1997-01-24

Family

ID=9415270

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9109097A Expired - Fee Related FR2679236B1 (fr) 1991-07-18 1991-07-18 Nouveaux sterouides substitues en position 6, leurs procedes d'obtention et des compositions pharmaceutiques en renfermant.

Country Status (14)

Country Link
EP (1) EP0595990A1 (fr)
JP (1) JPH06509108A (fr)
KR (1) KR100249554B1 (fr)
AU (2) AU2388492A (fr)
BR (1) BR9206282A (fr)
CA (1) CA2113475A1 (fr)
FI (1) FI940223A (fr)
FR (1) FR2679236B1 (fr)
HU (1) HU219456B (fr)
NO (1) NO305961B1 (fr)
OA (1) OA09929A (fr)
PL (3) PL172522B1 (fr)
TN (1) TNSN92064A1 (fr)
WO (1) WO1993002095A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69230069T2 (de) 1991-06-18 2000-05-25 Laboratoire Theramex S.A., Monaco Steroide enthaltende zusammensetzungen zur anwendung am auge und ihre verwendung zur behandlung des glaukoms

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1515284A (en) * 1974-05-21 1978-06-21 Gastaud J Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
US4512986A (en) * 1983-07-26 1985-04-23 Research Triangle Institute Progrestationally active steroids
FR2552766B1 (fr) * 1983-10-04 1987-06-26 Theramex Nouveau procede de preparation de derives de la serie du 17 a-hydroxy 19-nor progesterone
FR2645864B1 (fr) * 1989-04-13 1991-07-12 Theramex Nouveaux derives alcoyles en 17/21 de la 19-nor progesterone, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2647452A1 (fr) * 1989-05-24 1990-11-30 Theramex Nouveaux 19-nor steroides 6-methyles leurs procedes d'obtention, les compositions pharmaceutiques en renfermant et leur conversion en 19-nor pregnadienes 17-substitues

Also Published As

Publication number Publication date
FI940223A (fi) 1994-03-16
TNSN92064A1 (fr) 1993-06-08
AU6196696A (en) 1996-10-17
PL172502B1 (pl) 1997-10-31
EP0595990A1 (fr) 1994-05-11
OA09929A (fr) 1994-11-15
NO940159D0 (no) 1994-01-17
WO1993002095A1 (fr) 1993-02-04
FR2679236A1 (fr) 1993-01-22
JPH06509108A (ja) 1994-10-13
FI940223A0 (fi) 1994-01-17
AU691431B2 (en) 1998-05-14
CA2113475A1 (fr) 1993-02-04
KR100249554B1 (ko) 2000-03-15
HU9400134D0 (en) 1994-05-30
NO940159L (no) 1994-02-16
BR9206282A (pt) 1995-10-17
PL172677B1 (en) 1997-11-28
HU219456B (hu) 2001-04-28
NO305961B1 (no) 1999-08-23
HUT66021A (en) 1994-08-29
AU2388492A (en) 1993-02-23
PL172522B1 (pl) 1997-10-31

Similar Documents

Publication Publication Date Title
ITRM910696A1 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
FI922234A0 (fi) Kompositioner med laog loeslighet, vilka utgoers av paerlor belagda med laekemedel.
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
DE69106947D1 (de) Zyklodextrine enthaltende galenische Zusammensetzungen.
NL990010I2 (nl) Ä3HÜ-imidazo-Ä5,1-dÜ-1,2,3,5-tetrazine-4-on derivaten en farmaceutische samenstellingen, die deze d erivaten bevatten.
FI924777A0 (fi) Cytotoxiska bicyklo(7.3.1)tridek-4-en-2,6-diynfoereningar och foerfarande foer framstaellning av dessa
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
FI903759A0 (fi) Farmaceutisk komposition innehaollande n-acetylcystein foer oral administrering.
MA22978A1 (fr) Nouvelles compositions a base de derives de nomegestrol et leurs procedes d'obtention.
FR2682679B1 (fr) Nouveaux derives d'alkylpolyosides, leurs procedes de preparation et applications comme agents de surface.
FR2687401B1 (fr) Derives de la 1,4-dialkylpiperazine, procedes d'obtention et compositions pharmaceutiques les contenant.
HU9303113D0 (en) Pharmaceutical compositions containing 1,2-dithiol-3-thione-derivatives
FR2673964B3 (fr) Element d'ossature notamment pour construction bois.
FR2674755B1 (fr) Nouvelles compositions medicamenteuses immunostimulatrices.
FR2657872B2 (fr) Derive d'amidino-4 chromanne, procede d'obtention et compositions pharmaceutiques le contenant.
FR2679236B1 (fr) Nouveaux sterouides substitues en position 6, leurs procedes d'obtention et des compositions pharmaceutiques en renfermant.
DE3586817D1 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
FR2676224B1 (fr) Nouveaux sels d'ammonium quaternaire, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant.
FR2677250B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
FR2659556B1 (fr) Compositions a base d'arnica, et leurs utilisations notamment dans des compositions pharmaceutiques ou cosmetiques.
ITRM920535A1 (it) Composizione farmaceutica per la somministrazione attraverso le mucose.
DE69107742D1 (de) Substituierte 3,7,9-Trioxa-1-aza-2,8-diphosphaspiro[4.5]dekane und stabilisierte Zusammensetzungen.
FI924307A0 (fi) Regionselektiv syntes av antiinflammatoriska 1,5-diarylpyrazollaekemedel.
FI906009A0 (fi) Foerfarande foer framstaellning av des(64,65)-proinsulin.

Legal Events

Date Code Title Description
ST Notification of lapse